NCT07540403
- Conditions
- Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
- Locations
-
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome, Italy
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,310 public trials
520 recruiting studies
Recurrence trial results
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
NCT03761108
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Moffitt Cancer Center - McKinley Drive Tampa, Florida, United States
- Emory University Hospital Atlanta, Georgia, United States
- Indiana University_Michigan Street Indianapolis, Indiana, United States
NCT06330038
- Conditions
- Anesthesia, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
- Locations
-
- Samsung Medical Center Seoul, Seoul-teukbyeolsi, South Korea
NCT06610682
- Conditions
- BRAF V600E Mutation, Disease Attributes, Pathologic Processes, +2 more
- Locations
-
- Johns Hopkins Baltimore, Maryland, United States
NCT03328078
- Conditions
- Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +17 more
- Locations
-
- St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Mayo Clinic Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- Providence St. John's Health Center Santa Monica, California, United States
NCT07500753
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +15 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Recruiting
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
NCT05996185
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +19 more
- Locations
-
- Yale Cancer Center, Clinical Trials Office New Haven, Connecticut, United States
- Icahn School of Medicine at Mount Sinai New York, United States
Recruiting
New MRI Biomarkers in Head and Neck Cancers
NCT03483337
- Conditions
- Disease Attributes, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT07523555
- Conditions
- BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT07242963
- Conditions
- Disease Attributes, Glioma, Medulloblastoma, +15 more
- Locations
-
- Baylor College of Medicine Houston, Texas, United States
- MD Anderson Cancer Center Houston, Texas, United States